June 13: The Week in Cancer News
Researchers explore the causes of lung cancer in never-smokers, and findings support start to colonoscopy screening at age 45.
Progress Against Cancer
Researchers explore the causes of lung cancer in never-smokers, and findings support start to colonoscopy screening at age 45.
A blood test can detect breast cancer drug resistance, and a combination treatment improves outcomes in colorectal cancer.
AI can help doctors determine which breast cancer patients qualify for targeted therapy, and cancer deaths among women have increased with rising temperatures in some countries.
This month, the editors of AACR’s journals picked studies highlighting genetic parallels between cancer evolution and high-altitude physiology, data linking oil and gas exposure to childhood leukemia risk, and more.
The AACR Annual Meeting 2025, held April 25-30, featured six Plenary Sessions that explored exciting areas of cancer research, including cancer evolution; KRAS, extrachromosomal DNA (ecDNA), and cancer vaccines; innovative technology advancing organoid models,...
The latest edition of From the Bench features creative cancer research, including making tumors seem like pig organs, starving cancer with fat, and more.
Disasters present a threat to cancer care, and understanding prostate cancer screening recommendations after President Joe Biden’s diagnosis.
At the AACR Annual Meeting 2025, researchers and patient advocates shared insights into the impact of NIH funding cuts on cancer research.
Learn how a Gleason score is calculated to help determine the aggressiveness of prostate cancer, and how it could influence a patient's treatment.
Research unveiled at the AACR Annual Meeting 2025 highlighted advances in blood-based liquid biopsy tests to help improve cancer care.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now